inserts Search Results


90
ATCC atcc accession number
Atcc Accession Number, supplied by ATCC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/inserts/us08754199-69-53-53?v=ATCC
Average 90 stars, based on 1 article reviews
atcc accession number - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

99
Guangzhou JET Bio-Filtration bftc909 cells
BOC silencing suppresses cell migration in urothelial carcinoma cells. ( A ) qRT-PCR confirmed efficient knockdown of BOC expression in <t>BFTC909</t> cells using two independent shRNAs (**, p < 0.01, one-way ANOVA). ( B–D ) Representative images and quantification of Boyden chamber assays demonstrated significantly decreased migration in shBOC cells compared with controls (***, p < 0.001, one-way ANOVA). Scale bar: 200 µm, ( E,F ) RTCA migration assays showed impaired migration of BFTC909 cells after BOC knockdown (***, p < 0.001, two-way ANOVA with repeated measures and post-hoc tests).
Bftc909 Cells, supplied by Guangzhou JET Bio-Filtration, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/inserts/pmc13040342-90-7-21?v=Guangzhou+JET+Bio-Filtration
Average 99 stars, based on 1 article reviews
bftc909 cells - by Bioz Stars, 2026-07
99/100 stars
  Buy from Supplier

94
CELLTREAT Scientific inserts
BOC silencing suppresses cell migration in urothelial carcinoma cells. ( A ) qRT-PCR confirmed efficient knockdown of BOC expression in <t>BFTC909</t> cells using two independent shRNAs (**, p < 0.01, one-way ANOVA). ( B–D ) Representative images and quantification of Boyden chamber assays demonstrated significantly decreased migration in shBOC cells compared with controls (***, p < 0.001, one-way ANOVA). Scale bar: 200 µm, ( E,F ) RTCA migration assays showed impaired migration of BFTC909 cells after BOC knockdown (***, p < 0.001, two-way ANOVA with repeated measures and post-hoc tests).
Inserts, supplied by CELLTREAT Scientific, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/inserts/pmc12971498-303-12-13?v=CELLTREAT+Scientific
Average 94 stars, based on 1 article reviews
inserts - by Bioz Stars, 2026-07
94/100 stars
  Buy from Supplier

94
CELLTREAT Scientific permeable cell culture inserts
BOC silencing suppresses cell migration in urothelial carcinoma cells. ( A ) qRT-PCR confirmed efficient knockdown of BOC expression in <t>BFTC909</t> cells using two independent shRNAs (**, p < 0.01, one-way ANOVA). ( B–D ) Representative images and quantification of Boyden chamber assays demonstrated significantly decreased migration in shBOC cells compared with controls (***, p < 0.001, one-way ANOVA). Scale bar: 200 µm, ( E,F ) RTCA migration assays showed impaired migration of BFTC909 cells after BOC knockdown (***, p < 0.001, two-way ANOVA with repeated measures and post-hoc tests).
Permeable Cell Culture Inserts, supplied by CELLTREAT Scientific, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/inserts/bio_rxiv__64898__2026__03__12__711152-235-27-26?v=CELLTREAT+Scientific
Average 94 stars, based on 1 article reviews
permeable cell culture inserts - by Bioz Stars, 2026-07
94/100 stars
  Buy from Supplier

93
Illumina Inc hyb chamber inserts
BOC silencing suppresses cell migration in urothelial carcinoma cells. ( A ) qRT-PCR confirmed efficient knockdown of BOC expression in <t>BFTC909</t> cells using two independent shRNAs (**, p < 0.01, one-way ANOVA). ( B–D ) Representative images and quantification of Boyden chamber assays demonstrated significantly decreased migration in shBOC cells compared with controls (***, p < 0.001, one-way ANOVA). Scale bar: 200 µm, ( E,F ) RTCA migration assays showed impaired migration of BFTC909 cells after BOC knockdown (***, p < 0.001, two-way ANOVA with repeated measures and post-hoc tests).
Hyb Chamber Inserts, supplied by Illumina Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/inserts/pmc10544418__12957_2023_3189_MOESM13_ESM-1262-14-22?v=Illumina+Inc
Average 93 stars, based on 1 article reviews
hyb chamber inserts - by Bioz Stars, 2026-07
93/100 stars
  Buy from Supplier

92
Genesee Scientific inserts
BOC silencing suppresses cell migration in urothelial carcinoma cells. ( A ) qRT-PCR confirmed efficient knockdown of BOC expression in <t>BFTC909</t> cells using two independent shRNAs (**, p < 0.01, one-way ANOVA). ( B–D ) Representative images and quantification of Boyden chamber assays demonstrated significantly decreased migration in shBOC cells compared with controls (***, p < 0.001, one-way ANOVA). Scale bar: 200 µm, ( E,F ) RTCA migration assays showed impaired migration of BFTC909 cells after BOC knockdown (***, p < 0.001, two-way ANOVA with repeated measures and post-hoc tests).
Inserts, supplied by Genesee Scientific, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/inserts/pm39160175-189-19-20?v=Genesee+Scientific
Average 92 stars, based on 1 article reviews
inserts - by Bioz Stars, 2026-07
92/100 stars
  Buy from Supplier

94
CELLTREAT Scientific membrane inserts
BOC silencing suppresses cell migration in urothelial carcinoma cells. ( A ) qRT-PCR confirmed efficient knockdown of BOC expression in <t>BFTC909</t> cells using two independent shRNAs (**, p < 0.01, one-way ANOVA). ( B–D ) Representative images and quantification of Boyden chamber assays demonstrated significantly decreased migration in shBOC cells compared with controls (***, p < 0.001, one-way ANOVA). Scale bar: 200 µm, ( E,F ) RTCA migration assays showed impaired migration of BFTC909 cells after BOC knockdown (***, p < 0.001, two-way ANOVA with repeated measures and post-hoc tests).
Membrane Inserts, supplied by CELLTREAT Scientific, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/inserts/pmc13056709-28-23-25?v=CELLTREAT+Scientific
Average 94 stars, based on 1 article reviews
membrane inserts - by Bioz Stars, 2026-07
94/100 stars
  Buy from Supplier

94
CELLTREAT Scientific permeable inserts
BOC silencing suppresses cell migration in urothelial carcinoma cells. ( A ) qRT-PCR confirmed efficient knockdown of BOC expression in <t>BFTC909</t> cells using two independent shRNAs (**, p < 0.01, one-way ANOVA). ( B–D ) Representative images and quantification of Boyden chamber assays demonstrated significantly decreased migration in shBOC cells compared with controls (***, p < 0.001, one-way ANOVA). Scale bar: 200 µm, ( E,F ) RTCA migration assays showed impaired migration of BFTC909 cells after BOC knockdown (***, p < 0.001, two-way ANOVA with repeated measures and post-hoc tests).
Permeable Inserts, supplied by CELLTREAT Scientific, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/inserts/pmc13120886-22-11-18?v=CELLTREAT+Scientific
Average 94 stars, based on 1 article reviews
permeable inserts - by Bioz Stars, 2026-07
94/100 stars
  Buy from Supplier

94
Genesee Scientific f 12 50 50 mix culture media
BOC silencing suppresses cell migration in urothelial carcinoma cells. ( A ) qRT-PCR confirmed efficient knockdown of BOC expression in <t>BFTC909</t> cells using two independent shRNAs (**, p < 0.01, one-way ANOVA). ( B–D ) Representative images and quantification of Boyden chamber assays demonstrated significantly decreased migration in shBOC cells compared with controls (***, p < 0.001, one-way ANOVA). Scale bar: 200 µm, ( E,F ) RTCA migration assays showed impaired migration of BFTC909 cells after BOC knockdown (***, p < 0.001, two-way ANOVA with repeated measures and post-hoc tests).
F 12 50 50 Mix Culture Media, supplied by Genesee Scientific, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/inserts/pmc11815580-129-25-34?v=Genesee+Scientific
Average 94 stars, based on 1 article reviews
f 12 50 50 mix culture media - by Bioz Stars, 2026-07
94/100 stars
  Buy from Supplier

94
World Precision Instruments stx4 evom electrode
BOC silencing suppresses cell migration in urothelial carcinoma cells. ( A ) qRT-PCR confirmed efficient knockdown of BOC expression in <t>BFTC909</t> cells using two independent shRNAs (**, p < 0.01, one-way ANOVA). ( B–D ) Representative images and quantification of Boyden chamber assays demonstrated significantly decreased migration in shBOC cells compared with controls (***, p < 0.001, one-way ANOVA). Scale bar: 200 µm, ( E,F ) RTCA migration assays showed impaired migration of BFTC909 cells after BOC knockdown (***, p < 0.001, two-way ANOVA with repeated measures and post-hoc tests).
Stx4 Evom Electrode, supplied by World Precision Instruments, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/inserts/pm41519874-170-14-20?v=World+Precision+Instruments
Average 94 stars, based on 1 article reviews
stx4 evom electrode - by Bioz Stars, 2026-07
94/100 stars
  Buy from Supplier

Image Search Results


BOC silencing suppresses cell migration in urothelial carcinoma cells. ( A ) qRT-PCR confirmed efficient knockdown of BOC expression in BFTC909 cells using two independent shRNAs (**, p < 0.01, one-way ANOVA). ( B–D ) Representative images and quantification of Boyden chamber assays demonstrated significantly decreased migration in shBOC cells compared with controls (***, p < 0.001, one-way ANOVA). Scale bar: 200 µm, ( E,F ) RTCA migration assays showed impaired migration of BFTC909 cells after BOC knockdown (***, p < 0.001, two-way ANOVA with repeated measures and post-hoc tests).

Journal: Oncology Research

Article Title: Pre-Treatment BOC Expression as an Indicator of Lymphovascular Invasion and In Vitro Chemotherapeutic Response in Upper Tract Urothelial Carcinoma

doi: 10.32604/or.2026.070837

Figure Lengend Snippet: BOC silencing suppresses cell migration in urothelial carcinoma cells. ( A ) qRT-PCR confirmed efficient knockdown of BOC expression in BFTC909 cells using two independent shRNAs (**, p < 0.01, one-way ANOVA). ( B–D ) Representative images and quantification of Boyden chamber assays demonstrated significantly decreased migration in shBOC cells compared with controls (***, p < 0.001, one-way ANOVA). Scale bar: 200 µm, ( E,F ) RTCA migration assays showed impaired migration of BFTC909 cells after BOC knockdown (***, p < 0.001, two-way ANOVA with repeated measures and post-hoc tests).

Article Snippet: A total of 2 × 10 4 BFTC909 cells were seeded in each well of the upper chamber (cat. no. TCS003024; JET Biofil, Guangzhou, China).

Techniques: Migration, Quantitative RT-PCR, Knockdown, Expressing

BOC silencing enhances sensitivity to cisplatin and gemcitabine in BFTC909 cells. ( A – D ) Cell viability assays were performed in BFTC909 cells with BOC knockdown (shBOC#1) or control (shScramble) following treatment with ( A ) cisplatin, ( B ) gemcitabine, ( C ) paclitaxel, or ( D ) epirubicin at the indicated concentrations. Data are presented as mean ± SEM. All statistics were determined using the one-way ANOVA. **, p < 0.01; ***, p < 0.001; ns, not significant.

Journal: Oncology Research

Article Title: Pre-Treatment BOC Expression as an Indicator of Lymphovascular Invasion and In Vitro Chemotherapeutic Response in Upper Tract Urothelial Carcinoma

doi: 10.32604/or.2026.070837

Figure Lengend Snippet: BOC silencing enhances sensitivity to cisplatin and gemcitabine in BFTC909 cells. ( A – D ) Cell viability assays were performed in BFTC909 cells with BOC knockdown (shBOC#1) or control (shScramble) following treatment with ( A ) cisplatin, ( B ) gemcitabine, ( C ) paclitaxel, or ( D ) epirubicin at the indicated concentrations. Data are presented as mean ± SEM. All statistics were determined using the one-way ANOVA. **, p < 0.01; ***, p < 0.001; ns, not significant.

Article Snippet: A total of 2 × 10 4 BFTC909 cells were seeded in each well of the upper chamber (cat. no. TCS003024; JET Biofil, Guangzhou, China).

Techniques: Knockdown, Control